Ardelyx, Inc. (ARDX) vs SpyGlass Pharma, Inc. Common Stock (SGP)
A side-by-side comparison of Ardelyx, Inc. and SpyGlass Pharma, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ARDX
Ardelyx, Inc.
$3.28HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
SGP
SpyGlass Pharma, Inc. Common Stock
$25.09HealthcareDelayed quote: Oct 6, 2026, 3:34 PM EDT
Total return — ARDX vs SGP
growth of $100 · dividends reinvested · last 1yARDX -54.1% (-54.1%/yr)SGP -3.1% (-3.1%/yr)SGP compounded faster over this window
ARDX SGP
ARDX vs SGP: by the numbers
- •SGP is the larger company ($839M vs $810M market cap).
- •Both run net losses; SGP's is the smaller (0.00% vs -12.35% net margin).
Metrics side by side
Valuation
| Metric | ARDX | SGP |
|---|---|---|
| P/S ratio | 1.80 | N/A |
| P/B ratio | 5.44 | 3.61 |
Profitability
| Metric | ARDX | SGP |
|---|---|---|
| Gross margin | 93.96% | 0.00% |
| Operating margin | -7.86% | 0.00% |
| Net margin | -12.35% | 0.00% |
| ROE | -37.38% | -24.12% |
| ROIC | -7.99% | -26.54% |
Growth (annualized)
| Metric | ARDX | SGP |
|---|---|---|
| Revenue CAGR (5Y) | 105.14% | N/A |
| Total return CAGR (5Y) | 20.95% | N/A |
Go deeper
Dig into the metrics
Ardelyx ROESpyGlass Pharma, Inc. Common Stock ROEArdelyx operating marginSpyGlass Pharma, Inc. Common Stock operating marginArdelyx revenue growthSpyGlass Pharma, Inc. Common Stock revenue growthArdelyx free cash flowSpyGlass Pharma, Inc. Common Stock free cash flow
Ardelyx & SpyGlass Pharma, Inc. Common Stock appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.